Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review

X Zheng, Y Xu, W Guan, L Lin - Archives of virology, 2018 - Springer
Despite increased understanding of how viral infection is involved in asthma exacerbations,
it is less clear which viruses are involved and to what extent they contribute to asthma …

Socioeconomic impact of RSV hospitalization

M Young, L Smitherman - Infectious diseases and therapy, 2021 - Springer
Respiratory syncytial virus (RSV) disease is a significant cause of morbidity and
socioeconomic burden worldwide among young children. The majority of RSV-associated …

RSV epidemiology in Australia before and during COVID-19

GL Saravanos, N Hu, N Homaira, DJ Muscatello… - …, 2022 - publications.aap.org
RSV Epidemiology in Australia Before and During COVID-19 | Pediatrics | American Academy
of Pediatrics Skip to Main Content Disclaimer » Advertising AAP logo Search Close Shopping …

Respiratory syncytial virus–associated hospitalizations among young children: 2015–2016

B Rha, AT Curns, JY Lively, AP Campbell… - …, 2020 - publications.aap.org
BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of hospitalized acute
respiratory illness (ARI) among young children. With RSV vaccines and immunoprophylaxis …

Estimation of the timing and intensity of reemergence of respiratory syncytial virus following the COVID-19 pandemic in the US

Z Zheng, VE Pitzer, ED Shapiro, LJ Bont… - JAMA network …, 2021 - jamanetwork.com
Importance Respiratory syncytial virus (RSV) is a leading cause of hospitalizations in young
children. RSV largely disappeared in 2020 owing to precautions taken because of the …

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication

J Sourimant, CM Lieber, M Aggarwal, RM Cox, JD Wolf… - Science, 2022 - science.org
The COVID-19 pandemic has underscored the critical need for broad-spectrum therapeutics
against respiratory viruses. Respiratory syncytial virus (RSV) is a major threat to pediatric …

Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity

M Vono, A Huttner, S Lemeille, P Martinez-Murillo… - Cell reports, 2021 - cell.com
SARS-CoV-2 infection in children is less severe than it is in adults. We perform a
longitudinal analysis of the early innate responses in children and adults with mild infection …

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series

NM Scheltema, A Gentile, F Lucion… - The Lancet Global …, 2017 - thelancet.com
Background Respiratory syncytial virus (RSV) infection is an important cause of pneumonia
mortality in young children. However, clinical data for fatal RSV infection are scarce. We …

Estimated burden of community-onset respiratory syncytial virus–associated hospitalizations among children aged< 2 years in the United States, 2014–15

CS Arriola, L Kim, G Langley… - Journal of the …, 2020 - academic.oup.com
Background Respiratory syncytial virus (RSV) is a major cause of hospitalizations in young
children. We estimated the burden of community-onset RSV-associated hospitalizations …

Admissions for bronchiolitis at children's hospitals before and during the COVID-19 pandemic

KA Remien, JZ Amarin, CM Horvat… - JAMA Network …, 2023 - jamanetwork.com
Importance The COVID-19 pandemic has been associated with a transient decrease in
bronchiolitis hospitalizations compared with prepandemic patterns, but current effects …